Page last updated: 2024-08-23

daunorubicin and baumycins

daunorubicin has been researched along with baumycins in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (16.67)	18.7374
1990's	2 (33.33)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujii, S; Johdo, O; Kubo, K; Nishida, H; Okamoto, R; Takeuchi, T; Yoshimoto, A	2
Kouno, K; Matsuzawa, Y; Oki, T; Yoshimoto, A	1
Al-Mestarihi, A; Bachmann, BO; Liu, HW; Romo, A	1
Chlipala, GE; Hanna, PC; Newmister, SA; Nusca, TD; Scaglione, JB; Schofield, MM; Schultz, PJ; Sherman, DH; Tamayo-Castillo, G; Tripathi, A; Yim, I	1
Head, BM; Meyers, AF; Rubinstein, E	1

Reviews

1 review(s) available for daunorubicin and baumycins

Article	Year
Alternative pre-approved and novel therapies for the treatment of anthrax. BMC infectious diseases, 2016, Nov-03, Volume: 16, Issue:1 Topics: Alpha-Globulins; Anthrax; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Bacterial; Antitoxins; Bacillus anthracis; Bacterial Toxins; Daunorubicin; DNA Helicases; Doxorubicin; Drug Discovery; Fluoroquinolones; Humans; Interferon Inducers; Levofloxacin; Linezolid; Moxifloxacin; Ofloxacin; Polyketides; Serine Proteinase Inhibitors; Tilorone; Virulence	2016

Article

Year

Alternative pre-approved and novel therapies for the treatment of anthrax.

BMC infectious diseases, 2016, Nov-03, Volume: 16, Issue:1

Topics: Alpha-Globulins; Anthrax; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Bacterial; Antitoxins; Bacillus anthracis; Bacterial Toxins; Daunorubicin; DNA Helicases; Doxorubicin; Drug Discovery; Fluoroquinolones; Humans; Interferon Inducers; Levofloxacin; Linezolid; Moxifloxacin; Ofloxacin; Polyketides; Serine Proteinase Inhibitors; Tilorone; Virulence

2016

Other Studies

5 other study(ies) available for daunorubicin and baumycins

Article	Year
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization. The Journal of antibiotics, 1992, Volume: 45, Issue:8 Topics: Animals; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Daunorubicin; Leukemia L1210; Mice; Mutation; Streptomyces; Tumor Cells, Cultured	1992
Baumycin analogs isolated from Actinomadura sp. The Journal of antibiotics, 1981, Volume: 34, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Daunorubicin; Leukemia L1210; Mice; Nocardiaceae; Soil Microbiology	1981
Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. II. New anthracycline metabolites produced by a blocked mutant strain RPM-5. The Journal of antibiotics, 1993, Volume: 46, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; DNA Replication; DNA, Neoplasm; Fermentation; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; RNA, Neoplasm; Streptomyces; Tumor Cells, Cultured	1993
Nitrososynthase-triggered oxidative carbon-carbon bond cleavage in baumycin biosynthesis. Journal of the American Chemical Society, 2013, Aug-07, Volume: 135, Issue:31 Topics: Biosynthetic Pathways; Carbon; Daunorubicin; Genes, Bacterial; Hexosamines; Multigene Family; Oxidation-Reduction; Streptomyces	2013
Baulamycins A and B, broad-spectrum antibiotics identified as inhibitors of siderophore biosynthesis in Staphylococcus aureus and Bacillus anthracis. Journal of the American Chemical Society, 2014, Jan-29, Volume: 136, Issue:4 Topics: Anti-Bacterial Agents; Bacillus anthracis; Biological Products; Daunorubicin; Dose-Response Relationship, Drug; Escherichia coli; High-Throughput Screening Assays; Microbial Sensitivity Tests; Molecular Conformation; Siderophores; Staphylococcus aureus; Structure-Activity Relationship	2014